提高新药上市许可标准。 - Suppr

Raising the bar for market authorisation of new drugs.

作者信息

Naci Huseyin, Cylus Jonathan, Vandoros Sotiris, Sato Azusa, Perampaladas Kumar

机构信息

LSE Health, London School of Economics and Political Science, London, UK.

出版信息

BMJ. 2012 Aug 7;345:e4261. doi: 10.1136/bmj.e4261.

DOI:10.1136/bmj.e4261

PMID:22872693

Abstract

摘要

相似文献

Raising the bar for market authorisation of new drugs.

BMJ. 2012 Aug 7;345:e4261. doi: 10.1136/bmj.e4261.

Drug marketing exclusivity under United States and European Union law.

Food Drug Law J. 2004;59(4):479-518.

Potential pathways for abbreviated approval of generic biologics under existing law and proposed reforms to the law.

Food Drug Law J. 2007;62(1):77-137.

The FDA's critical path initiative: a brief introduction.

Clin Ther. 2009 Nov;31(11):2572-3. doi: 10.1016/j.clinthera.2009.11.035.

FDA not NIH can speed new drugs.

Nature. 2011 Apr 14;472(7342):169. doi: 10.1038/472169a.

Off-label promotion.

Am J Ther. 2006 Sep-Oct;13(5):387. doi: 10.1097/01.mjt.0000245220.98041.34.

GATT implementation and generic drug approval.

Food Drug Law J. 1996;51(2):295-302.

A survey of developments in food and drug law from July 1998 to November 1999.

Food Drug Law J. 2000;55(1):35-56.

Drug development for neglected diseases - the trouble with FDA review vouchers.

N Engl J Med. 2008 Nov 6;359(19):1981-3. doi: 10.1056/NEJMp0806684.

PLIVA v. Mensing: generic consumers' unfortunate hand.

Yale J Health Policy Law Ethics. 2012 Summer;12(2):209-63.

引用本文的文献

"Drugs to avoid" to improve quality use of medicines: how is Australia faring?

J Pharm Policy Pract. 2021 Jul 13;14(1):60. doi: 10.1186/s40545-021-00346-3.

Methods and Designs of Modern Breast Cancer Confirmatory Trials.

Cancers (Basel). 2021 Jun 2;13(11):2757. doi: 10.3390/cancers13112757.

Continual proteomic divergence of HepG2 cells as a consequence of long-term spheroid culture.

Sci Rep. 2021 May 25;11(1):10917. doi: 10.1038/s41598-021-89907-9.

Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making.

Front Pharmacol. 2020 Feb 5;11:43. doi: 10.3389/fphar.2020.00043. eCollection 2020.

Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania.

Wellcome Open Res. 2019 Apr 16;4:70. doi: 10.12688/wellcomeopenres.15236.1. eCollection 2019.

Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13.

BMJ. 2017 Oct 4;359:j4530. doi: 10.1136/bmj.j4530.

Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study.

Br J Sports Med. 2015 Nov;49(21):1414-22. doi: 10.1136/bjsports-2015-f5577rep.

Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study.

BMJ. 2013 Oct 1;347:f5577. doi: 10.1136/bmj.f5577.

Relative efficacy and effectiveness assessment of new pharmaceuticals in three EU member states: current practices and outcome agreement between Belgium, the Netherlands and France.

Eur J Clin Pharmacol. 2013 Dec;69(12):2037-43. doi: 10.1007/s00228-013-1577-6. Epub 2013 Sep 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Raising the bar for market authorisation of new drugs.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献